Removal of LGBTQ+ option from 988 hotline is straining overburdened Texas crisis centers

• by Stephen Simpson/the Texas Tribune

• January 23, 2026

Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings

• May 6, 2026

Semaglutide Tested in Alcohol Use Disorder

Randomized trial found improvements in alcohol consumption and metabolic outcomes, with gastrointestinal adverse events more common with treatment

• by Kathryn Wighton

• May 6, 2026

• 5 min

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min